Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy
The purpose of this study is to investigate the effect of semaglutide in women with Polycystic Ovarian Syndrome(PCOS ) and determine potential therapeutic benefits.
Polycystic Ovary Syndrome
DRUG: Semaglutide
Number of appropriate weekly dose, To access the compliances of the therapy, 4 weeks|Number of days on therapy, To access the persistence on Semaglutide, 4 weeks
measure the Weight in kilograms, To access the weight changes during therapy, 4 weeks|Numbers of days with exercise changes, To access the ability to do exercise during the therapy, 4 weeks
The study mainly focused for the following objectives:

To determine the effect of semaglutide on ovulation and menstrual regularity. To determine the effect of semaglutide on androgen levels, namely testosterone, sex hormone binding globulin, and changes in hirsutism.

To determine changes in weight, body mass index (BMI), and Glycated Hemoglobin( HbA1c) with semaglutide therapy.